Transcriptomics

Dataset Information

0

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells


ABSTRACT: Background: OX40 (CD134) is a co-stimulatory molecule of the tumor necrosis factor receptor (TNFR) superfamily, that is currently investigated as a target for cancer immunotherapy. However, despite promising results in murine tumor models, the clinical efficacy of agonistic αOX40 antibodies in treatment of cancer patients has fallen short of the high expectation in earlier stage trials. Methods: Using lymphocytes from resected tumor, tumor-free tissue and PBMC of 4 hepatocellular and colorectal cancer patients, we performed RNA-Seq to evaluate OX40-mediated transcriptional changes in CD4+ and CD8+ human tumor-infiltrating lymphocytes (TILs). Results: The transcriptional landscape of CD4+ and CD8+ TILs shifted towards a pro-survival, inflammatory and chemotactic profile upon treatment with αOX40_v12.

ORGANISM(S): Homo sapiens

PROVIDER: GSE152904 | GEO | 2020/06/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-01-03 | E-GEOD-43260 | biostudies-arrayexpress
| phs001824 | dbGaP
2022-11-09 | PXD034059 | Pride
2021-05-25 | GSE157893 | GEO
2022-02-17 | PXD026447 | Pride
2024-02-14 | PXD031794 | Pride
2023-02-20 | PXD036811 | Pride
2013-02-07 | E-GEOD-27928 | biostudies-arrayexpress
2013-12-31 | E-GEOD-42824 | biostudies-arrayexpress
2024-03-15 | PXD045710 | Pride